Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Protein Profile Identified in Blood of Chronic Sinusitis Sufferers

By Labmedica staff writers
Posted on 23 Apr 2008
A protein profile identified in the blood of chronic sinusitis sufferers will help physicians to diagnose and treat the disease.

Scientists analyzed protein expression in the blood using surface enhanced laser desorption ionization time-of-flight mass spectroscopy (SELDI-TOF-MS). More...
They found that among 96 chronic sinusitis patients that there was a protein profile missing in 38 healthy controls. The test is about 88% accurate.

"We can diagnose this disease with a totally objective test that does not depend on symptoms or observations,” said Dr. Stilianos E. Kountakis, vice chair of the department of otolaryngology-head and neck surgery in the Medical College of Georgia School of Medicine (MCG; Augusta, GA, USA). He is corresponding author on the study published in the March/April 2008 issue of the American Journal of Rhinology.

To be classified chronic, sinusitis has to continue for at least 12 weeks. Causes include bacterial infections, respiratory inflammation, sinus polyps, and mucosal disease. Some causes, such as polyps and asthma, have a genetic predisposition. "You may have a bacterial infection, allergies, mechanical problems,” Dr. Kountakis said. "There are numerous genes that control respiratory function. Any of these things can go wrong to predispose the patient to develop chronic sinusitis.”

Diagnosing this chronically irritating disease, characterized by dripping noses, sinus pressure, congestion, and difficulty in breathing, is currently rather subjective. Patients describe their symptoms and doctors look at their sinuses with an endoscope and sometimes a computerized tomography scan. "… Overall management of [chronic sinusitis] is still hampered by the lack of quantifiable, molecular, and genetic markers to aid in screening,” the scientists wrote.


Related Links:
Medical College of Georgia School of Medicine

New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Urine Test Strips
LabStrip U12 mALB/CREA
New
Gold Member
Genetic Type 1 Diabetes Risk Test
T1D GRS Array
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The study identified a distinct immune signature associated with treatment-resistant myasthenia gravis (Dodd, Katherine C. et al., Med (2026). DOI: 10.1016/j.medj.2025.100987)

Immune Signature Identified in Treatment-Resistant Myasthenia Gravis

Myasthenia gravis is a rare autoimmune disorder in which immune attack at the neuromuscular junction causes fluctuating weakness that can impair vision, movement, speech, swallowing, and breathing.... Read more

Industry

view channel
Image: The initiative aims to speed next-generation diagnostic development during early pathogen emergence (photo courtesy of 123RF)

Cepheid Joins CDC Initiative to Strengthen U.S. Pandemic Testing Preparednesss

Cepheid (Sunnyvale, CA, USA) has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four national collaborators in a federal initiative to speed rapid diagnostic technologies... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.